Michael Schmertzler, Director at PTC THERAPEUTICS, INC. (PTCT), sold 1,000 shares at $44.86 ($45K) on 2023-06-07, disclosed to the SEC on 2023-06-09.
Scheduled sale ($45k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| PTCT | SELL | 2026-09-18 | $1.3M | — | Filing → |
| PTCT | SELL | 2026-09-11 | $1.4M | — | Filing → |
| PTCT | SELL | 2026-08-28 | $1.8M | — | Filing → |